2192.HK

Medlive Technology Co., Ltd. 2192.HK

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 2192.HK 1858.HK 2373.HK 6078.HK 2005.HK 2609.HK 1302.HK 3613.HK 0775.HK 1672.HK
6M -0.17 % 72.08 % 93.29 % -6.24 % -4.03 % 27.33 % 46.10 % 4.48 % 19.74 % 89.68 %
YTD 18.23 % 82.30 % 80.34 % -4.36 % -15.13 % 27.33 % 50.36 % 5.60 % 121.95 % 189.20 %
1Y 30.16 % 90.62 % 93.06 % -25.64 % -25.71 % 27.33 % 50.36 % 6.11 % 89.58 % 594.07 %
3Y 59.22 % 11.74 % 8.87 % -68.24 % -21.86 % 27.33 % -27.46 % -7.23 % 46.77 % 292.05 %
5Y -62.97 % -59.30 % 8.87 % -70.93 % -35.15 % 27.33 % -2.37 % 7.00 % 2.25 % 213.38 %
10Y -62.97 % 474.05 % 8.87 % -48.58 % 44.44 % 27.33 % 87.27 % -6.74 % 22.97 % -33.07 %
From the beginning -62.97 % 425.87 % 8.87 % -48.58 % 2 331 442.01 % 27.33 % 724.00 % 35.68 % -68.70 % -33.07 %

Dividend

Medlive Technology Co., Ltd.

Beijing Chunlizhengda Medical Instruments Co., Ltd.

Beauty Farm Medical and Health Industry Inc.

Hygeia Healthcare Holdings Co., Limited

SSY Group Limited

Beijing Tong Ren Tang Chinese Medicine Company Limited

CK Life Sciences Int'l., (Holdings) Inc.